In Episode 3 of Exploration Science, Trishul Shah, Director of Business Development at PolyPeptide Group, walks through the process of personalized medicine from needle to needle. Jon Collins, Vice President of Business Development at CEM, also joins us to discuss some challenges faced by the field of peptide-based personalized medicine and opportunities for technology to help.
Andrea Castro, Maurizio Zanetti, Hannah Carter. Neoantigen Controversies. Annual Review of Biomedical Data Science 2021 4:1, 227-253 https://doi.org/10.1146/annurev-biodatasci-092820-112713
https://www.polypeptide.com/wp-content/uploads/2019/12/NeoAntigen.pdf
https://www.polypeptide.com/neoantigen-peptides-napp/
